News
US House of Representatives: Amendment to FDA Modernization Act will save animals
Friday, 10 June 2022 09:27The U.S. House of Representatives has overwhelmingly passed the FDA Modernization Act as an amendment to a larger package of FDA-related reforms that could prevent millions of animal tests in the coming years and provide safer and more effective medicines to countless patients in need of treatment.
Commentary: the Netherlands introduces professorship for transition to animal-free procedures
Wednesday, 01 June 2022 12:01As of June 1, 2022, the Faculty of Veterinary Medicine at Utrecht University has established a professorship for the "evidence-based transition to animal-free innovations." The task of the veterinarian Merel Ritskes-Hoitinga is to accelerate the acceptance of animal-free procedures. The scientist, who used to conduct animal experiments herself, is now clearly committed to the goal of research without animal experiments. She wants to achieve this by improving cooperation between science, industry and regulatory authorities.
Traveling through the hydrogel with laser light
Monday, 30 May 2022 14:24A team of researchers from the Vienna University of Technology has developed a new hydrogel. It has an accessory molecule that can give cells a "marching direction" after irradiation with laser light. This allows microtissue structures, such as a blood vessel in an organoid - which is a tissue replica that is intended to replace animal testing - to be created specifically in the desired location.
University of Konstanz works on animal-free methods for implementation in the new EU chemicals strategy
Monday, 30 May 2022 13:16In order to achieve a better assessment of environmental chemicals, the EU has launched the international partnership PARC - short for "European Partnership for the Assessment of Risk from Chemicals". It involves 199 research groups from 28 countries and three EU agencies. The aim is to close gaps in knowledge about the effects of chemicals, promote innovation and gradually eliminate animal testing.
3Rs Science Prize 2022: Call for submissions
Monday, 30 May 2022 10:11The European Partnership for Alternatives to Animal Testing (EPAA) aims to promote the development, validation and acceptance of 3Rs alternative approaches (replacement, reduction and refinement of testing on animals). The 3Rs science prize is granted every two years to a scientist with an outstanding contribution to 3Rs. We want to promote positive contributions from industry or academia and encourage more scientists to focus their research on the 3Rs goals.
Würzburg: Cervical organoids for research into carcinogenesis
Tuesday, 17 May 2022 14:19Together with her team, Dr. Cindrilla Chumduri, group leader at the Department of Microbiology at Julius-Maximilians-Universität Würzburg (JMU), has developed organoids of the female cervix.
Scientists from the Paul Ehrlich Institute research prize winners
Monday, 09 May 2022 14:13Dr. Beate Krämer and Dr. Heike Behrensdorf-Nicol, scientists from the Department of Veterinary Medicine at the Paul Ehrlich Institute, have won the Research Prize of the State of Rhineland-Palatinate for their research on the "Relevance of the Irreversibility Test for Tetanus Toxoids".
Recombinant Antibody Challenge offers grants for antibodies
Thursday, 05 May 2022 18:48PETA Science Consortium International e.V., the Physicians Committee for Responsible Medicine (PCRM), and the Alternatives Research and Development Foundation (ARDF) are offering grants for free catalogue recombinant antibodies for use in research and testing.
Reutlingen: Innovative chip model to research obesity
Wednesday, 27 April 2022 09:41A team of researchers from the Natural and Medical Sciences Institute in Reutlingen (NMI), together with colleagues from the Medical Faculty of the Tübingen University as well as from the Fraunhofer Institute IGB, has developed an obesity model on a chip. The model is called Mix & Match and integrates all important cellular components that can also be found in human white adipose tissue.
Florida: New neuropathy model on-chip for drug studies of rare diseases
Friday, 22 April 2022 12:34A cell-based neuropathy disease model on-chip developed by Hesperos Inc. in Florida and colleagues is able to successfully recapitulate the neurophysiological features of two rare autoimmune demyelinating neuropathies. Additionally, it has been shown that the model is suitable for assessing the efficacy of new therapeutics.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.